Nu Skin Enterprises - NUS Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings or view top-rated stocks.

2 equities research analysts have issued 1-year price targets for Nu Skin Enterprises' shares. Their NUS share price forecasts range from $34.00 to $75.00. On average, they predict the company's share price to reach $48.00 in the next year. This suggests a possible upside of 18.5% from the stock's current price.
View analysts price targets for NUS or view top-rated stocks among Wall Street analysts.

Nu Skin Enterprises' stock was trading at $50.75 on January 1st, 2022. Since then, NUS shares have decreased by 20.2% and is now trading at $40.52.
View the best growth stocks for 2022 here.

Nu Skin Enterprises saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 1,960,000 shares, a decrease of 46.6% from the October 31st total of 3,670,000 shares. Based on an average daily volume of 526,700 shares, the days-to-cover ratio is presently 3.7 days. Approximately 4.1% of the shares of the stock are short sold.
View Nu Skin Enterprises' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 15th 2023.
View our NUS earnings forecast.

Nu Skin Enterprises, Inc. (NYSE:NUS) issued its quarterly earnings results on Wednesday, November, 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.11. The company had revenue of $641.15 million for the quarter, compared to analyst estimates of $639.19 million. Nu Skin Enterprises had a net margin of 1.61% and a trailing twelve-month return on equity of 17.44%. During the same quarter last year, the firm posted $1.08 earnings per share.

Nu Skin Enterprises announced a quarterly dividend on Wednesday, November 2nd. Stockholders of record on Friday, November 25th will be given a dividend of $0.385 per share on Wednesday, December 7th. This represents a $1.54 dividend on an annualized basis and a yield of 3.80%. The ex-dividend date is Wednesday, November 23rd.
Read our dividend analysis for NUS.

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.76%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 208.11%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NUS will have a dividend payout ratio of 51.85% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

Nu Skin Enterprises updated its fourth quarter 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of $0.40-$0.60 for the period, compared to the consensus earnings per share estimate of $1.09. The company issued revenue guidance of $500.00 million-$550.00 million, compared to the consensus revenue estimate of $645.47 million.

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Nu Skin Enterprises' stock is owned by a number of institutional and retail investors. Top institutional investors include State Street Corp (19.16%), Vanguard Group Inc. (11.94%), BlackRock Inc. (11.65%), Renaissance Technologies LLC (5.15%), Dimensional Fund Advisors LP (3.82%) and Bank of New York Mellon Corp (1.71%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends.

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NUS stock can currently be purchased for approximately $40.52.

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $2.00 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $0.74 on an earnings per share basis.

The company employs 4,600 workers across the globe.

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for the company is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at investorrelations@nuskin.com, or via fax at 801-345-5999.